Search details
1.
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma.
Cancer
; 126(16): 3674-3688, 2020 08 15.
Article
in English
| MEDLINE | ID: mdl-32497261
2.
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Cancer
; 123(21): 4147-4157, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28662313
3.
Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas.
Strahlenther Onkol
; 192(2): 92-101, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26636141
4.
A design of a DICOM-RT-based tool box for nonrigid 4D dose calculation.
J Appl Clin Med Phys
; 17(2): 99-111, 2016 03 08.
Article
in English
| MEDLINE | ID: mdl-27074476
5.
Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Int J Cancer
; 136(4): E127-35, 2015 Feb 15.
Article
in English
| MEDLINE | ID: mdl-25196065
6.
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
Cancer
; 121(8): 1328-38, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25529384
7.
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Cancer
; 121(16): 2720-9, 2015 Aug 15.
Article
in English
| MEDLINE | ID: mdl-25946469
8.
The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients.
Qual Life Res
; 23(1): 311-6, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-23775604
9.
Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong.
Cancer Causes Control
; 21(9): 1461-6, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20454843
10.
Real-time monitoring and control on deep inspiration breath-hold for lung cancer radiotherapy--combination of ABC and external marker tracking.
Med Phys
; 37(9): 4673-83, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20964186
11.
High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Int J Radiat Oncol Biol Phys
; 70(2): 361-7, 2008 Feb 01.
Article
in English
| MEDLINE | ID: mdl-17892917
12.
Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.
Radiother Oncol
; 87(1): 24-8, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18334273
13.
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Int J Radiat Oncol Biol Phys
; 100(3): 630-638, 2018 03 01.
Article
in English
| MEDLINE | ID: mdl-29413277
14.
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
Oral Oncol
; 77: 16-21, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29362121
15.
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.
J Clin Oncol
; : JCO2018777847, 2018 Jul 10.
Article
in English
| MEDLINE | ID: mdl-29989858
16.
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
Int J Radiat Oncol Biol Phys
; 101(5): 1078-1086, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29885997
17.
Intercostal nerve blockade for cancer pain: effectiveness and selection of patients.
Hong Kong Med J
; 13(4): 266-70, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17664531
18.
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
J Clin Oncol
; 23(28): 6966-75, 2005 Oct 01.
Article
in English
| MEDLINE | ID: mdl-16192584
19.
Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys
; 66(1): 142-51, 2006 Sep 01.
Article
in English
| MEDLINE | ID: mdl-16904519
20.
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Radiother Oncol
; 79(1): 27-33, 2006 Apr.
Article
in English
| MEDLINE | ID: mdl-16626829